Device shows potential in preventing stroke by blocking clots

10/3/2013 | Charleston Regional Business Journal (S.C.)

PMG Research is conducting a clinical trial comparing the effectiveness of St. Jude Medical's Amplatzer cardiac plug, an anti-clotting device, to anticoagulant therapy. The device is inserted into a patient's leg via catheter and blocks part of the heart to keep clots from flowing into the bloodstream. Researcher Dr. Matthew O'Steen said the Amplatzer shows promise in stroke prevention.

View Full Article in:

Charleston Regional Business Journal (S.C.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN